Curcumin BioBDMC inhibits a second key protein (MSK1) involved in activating inflammation.
Regular Curcumin of many types tested and displayed in the same graph cannot inhibit (stop) this protein (MSK1).
Ultimately: Curcumin BioBDMC inhibits two key proteins (MSK1 and NF-kB) while regular curcumin 95% only inhibits one of these (NF-kB) as is commonly known to be its anti-inflammatory mechanism.